OpenAlex
PricingAboutJobs
Log inGet started
Work

Cannabinoid Receptor 1 Blocker Rimonabant (SR 141716) for Treatment of Alcohol Dependence: Results From a Placebo-Controlled, Double-Blind Trial

HTML

Year: 2008
Type: article
Source: Journal of Clinical Psychopharmacology
DOI: 10.1097/jcp.0b013e318172b8bc
Authors: Michael Soyka, Gabriele Koller, Peggy Schmidt, Otto-Michael Lesch, Markus Leweke, Christoph Fehr, Horst Gann, Karl F. Mann
Institutions: Privatklinik Meiringen, Ludwig-Maximilians-Universität München, University of Vienna, University of Cologne, Johannes Gutenberg University Mainz, University of Freiburg, Heidelberg University, Central Institute of Mental Health
Language: English

Topic: Substance Abuse Treatment and Outcomes
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Keywords: rimonabant, SR141716, alcoholism, alcohol relapse prevention, endocannabinoid system, alcohol detoxification, heavy drinking, weight loss, leptin, depression, drug safety and tolerability
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2021211846
FWCI: 8.02
Cites: 57
Cited by: 142
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security